Mesalamine
Pricing Report NDC 60687-264-25

Latest NADAC: $6.61956 per EA · Effective Feb 20, 2019 · Est. package price $198.59 (30 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Mesalamine (NDC 60687-264-25) is $6.61956 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 20, 2019.

As a provided by American Health Packaging, this medication is distributed in a 30 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (60687-264-95) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$6.61956
Per EA

Effective Date
Feb 20, 2019
Billable Units
30 EA
Estimated Package Price
$198.59
Data Status
As of Feb 27, 2019
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (60687-264-95)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2016, the NADAC wholesale price for (NDC ) has moved within a range of $5.13731 to $6.63822 per EA. Over this 2 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.1373 - $6.6382
Market Volatility
29.22% Variance
Latest Trend
0.28%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Feb 20, 2019 $6.61956 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 23, 2019 $6.63822 EAC/I - Chain or Independent PharmacyCode 3, 6G - Generic
Dec 19, 2018 $5.99011 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 17, 2018 $5.23132 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 17, 2018 $5.23132 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Sep 19, 2018 $5.30298 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 22, 2018 $5.13731 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 18, 2018 $5.35934 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 20, 2018 $5.37598 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 23, 2018 $5.49922 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 18, 2018 $5.37519 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 21, 2018 $5.22515 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026